EUVIMEDEUVIMED entdecken
Open Access

Spectrum of clonal hematopoiesis in VEXAS syndrome

Fernanda Gutierrez-Rodrigues iD, Yael Kusne iD, Jenna Fernandez, Terra Lasho, Ruba Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy Finke, Matthew J Koster, Abhishek Mangaonkar, Kenneth J Warrington, Kebede Begna iD und 24 weitere

Blood Journal · 2023

DOI: 10.1182/blood.2022018774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Journal, 2023. Verfasst von Fernanda Gutierrez-Rodrigues und 35 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Branch, National Heart, Lung, and Blood Institute, National institutes of Health, Bethesda, MD. Hauptthemen laut MEDLINE: Dermatitis, Clonal Hematopoiesis. Die Arbeit wurde bisher 44-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VEXAS is caused by somatic mutations in UBA1 (UBA1mut) and characterized by heterogenous systemic auto-inflammation and progressive hematologic manifestations, meeting criteria for myelodysplastic syndrome (MDS) and plasma cell dyscrasias. The landscape of myeloid-related gene mutations leading to typical clonal hematopoiesis (CH) in these patients is unknown. Retrospectively, we screened 80 VEXAS patients for CH in their peripheral blood (PB) and correlated findings with clinical outcomes in 77. UBA1mutwere most common at hotspot p.M41 (median variant allele frequency/VAF = 75%). Typical CH mutations co-occurred with UBA1mut in 60% of patients, mostly in DNMT3A and TET2, and were not associated with inflammatory or hematologic manifestations. In prospective single-cell proteogenomic sequencing (scDNA), UBA1mutwas the dominant clone, present mostly in branched clonal trajectories. Based on integrated bulk and scDNA analyses, clonality in VEXAS followed two major patterns: with either typical CH preceding UBA1mutselection in a clone (Pattern 1), or occurring as an UBA1mutsubclone or in independent clones (Pattern 2). VAF in PB differed markedly between DNMT3A and TET2 clones (median VAF of 25% vs 1%). DNMT3A and TET2 clones associated with hierarchies representing patterns 1 and 2, respectively. Overall survival for all patients was 60% at 10 years. Transfusion-dependent anemia, moderate thrombocytopenia, and typical CH mutations, each correlated with poor outcome. In VEXAS, UBA1mut cells are the primary cause of systemic inflammation and marrow failure, being a new molecularly defined somatic entity associated with MDS. VEXAS-associated MDS is distinct from classical MDS in its presentation and clinical course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatitisClonal HematopoiesisSkin Diseases, GeneticRetrospective StudiesHumansMutationProspective StudiesMyelodysplastic Syndromes

Autor:innen und Institutionen

  • Hematology Branch, National Heart, Lung, and Blood Institute, National institutes of Health, Bethesda, MD.
  • Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ.
  • Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National institutes of Health, Bethesda, MD.
  • Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.

ORCID-Profile: Fernanda Gutierrez-Rodrigues, Yael Kusne, Kebede Begna, Zhuoer Xie, Taxiarchis Kourelis, Horatiu Olteanu, Sachiko Kajigaya, Sofia Rosenzweig, Rodrigo T Calado, Emma M Groarke, Mrinal M Patnaik

Zitieren

APA

Gutierrez-Rodrigues, F., Kusne, Y., Fernandez, J., Lasho, T., Shalhoub, R., Ma, X., Alessi, H., Finke, C., Koster, M. J., Mangaonkar, A., Warrington, K. J., Begna, K., Xie, Z., Ombrello, A. K., Viswanatha, D., Ferrada, M., Wilson, L., Go, R., Kourelis, T., …, & Patnaik, M. M. (2023). Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood Journal. https://doi.org/10.1182/blood.2022018774

Vancouver

Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho T, Shalhoub R, Ma X, et al. Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood Journal. 2023. doi:10.1182/blood.2022018774

BibTeX
@article{GutierrezRodrigues2023,
  author = {Gutierrez-Rodrigues, Fernanda and Kusne, Yael and Fernandez, Jenna and Lasho, Terra and Shalhoub, Ruba and Ma, Xiaoyang and Alessi, Hugh and Finke, Christy and Koster, Matthew J and Mangaonkar, Abhishek and Warrington, Kenneth J and Begna, Kebede and Xie, Zhuoer and Ombrello, Amanda K and Viswanatha, David and Ferrada, Marcela and Wilson, Lorena and Go, Ronald and Kourelis, Taxiarchis and Reichard, Kaaren and Olteanu, Horatiu and Darden, Ivana and Hironaka, Dalton and Alemu, Lemlem and Kajigaya, Sachiko and Rosenzweig, Sofia and Calado, Rodrigo T and Groarke, Emma M and Kastner, Daniel L and Calvo, Katherine R and Wu, Colin O and Grayson, Peter C and Young, Neal S and Beck, David B and Patel, Bhavisha A and Patnaik, Mrinal M},
  title = {Spectrum of clonal hematopoiesis in VEXAS syndrome},
  journal = {Blood Journal},
  year = {2023},
  doi = {10.1182/blood.2022018774}
}
Kostenlos starten →